RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions (2022)
- Authors:
- Macedo, Mariana Petaccia de - A.C.Camargo Cancer Center
- Melo, Fernanda Machado de - A.C.Camargo Cancer Center
- Ribeiro, Júlia da Silva - A.C.Camargo Cancer Center
- Mello, Celso Abdon Lopes de - A.C.Camargo Cancer Center
- Begnami, Maria Dirlei Ferreira de Souza - A.C.Camargo Cancer Center
- Soares, Fernando Augusto
- Carraro, Dirce Maria - A.C.Camargo Cancer Center
- Cunha, Isabela Werneck da - A.C.Camargo Cancer Center
- Autor USP: SOARES, FERNANDO AUGUSTO - FO
- Unidade: FO
- Assunto: NEOPLASIAS
- Language: Inglês
- Imprenta:
- Publisher place: Orchard Park
- Date published: 2022
- Source:
- Título: Oncoscience
- ISSN: 2331-4737
- Volume/Número/Paginação/Ano: Online, 2015
-
ABNT
MACEDO, Mariana Petaccia de et al. RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions. Oncoscience, 2022Tradução . . Disponível em: https://pubmed.ncbi.nlm.nih.gov/25859555/. Acesso em: 13 mar. 2026. -
APA
Macedo, M. P. de, Melo, F. M. de, Ribeiro, J. da S., Mello, C. A. L. de, Begnami, M. D. F. de S., Soares, F. A., et al. (2022). RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions. Oncoscience. Recuperado de https://pubmed.ncbi.nlm.nih.gov/25859555/ -
NLM
Macedo MP de, Melo FM de, Ribeiro J da S, Mello CAL de, Begnami MDF de S, Soares FA, Carraro DM, Cunha IW da. RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions [Internet]. Oncoscience. 2022 ;[citado 2026 mar. 13 ] Available from: https://pubmed.ncbi.nlm.nih.gov/25859555/ -
Vancouver
Macedo MP de, Melo FM de, Ribeiro J da S, Mello CAL de, Begnami MDF de S, Soares FA, Carraro DM, Cunha IW da. RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions [Internet]. Oncoscience. 2022 ;[citado 2026 mar. 13 ] Available from: https://pubmed.ncbi.nlm.nih.gov/25859555/ - Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study
- A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma – a validation on an external data set
- Single nucleotide variants in immuneresponse genes and the tumor microenvironment composition predict progression of mantle cell lymphoma
- A call to action: molecular pathology in Brazil
- Digital Pathology in Latin America
- Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo
- Biopsia de linfonodos em paciente com sida . Experiencia do servico de patologia do hcfmrp / usp, no periodo de 1988 a 1993
- Role of GATA3 as a potential adjunct marker in the differential diagnosis of Paget’s disease of the nipple
- Synchronous ameloblastoma and orthokeratinized odontogenic cyst of the mandible
- The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation status
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
